CASI Pharma Inc Live Stock Price Today, Share Analysis and Chart

Name: CASI Pharmaceuticals Inc: Is Infosys Ltd. worth buying?
Item: CASI Pharmaceuticals Inc
Rating: 1.41350
Author: Trendlyne DVM scores

about

CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is us...

0.99 -0.01 (-1.00%)

67.96% Fall from 52W High

31,235

XNAS Volume

XNAS 22 Jan, 2026 4:30 PM (EST)

Board Meeting

The next board meeting for CASI Pharma Inc is on 28 Jan 2026 for the purpose of CASI Pharmaceuticals Inc Annual General Meeting for 2024 See details

Not Eligible

Expensive Valuation

15.5 / 100

Technically Neutral

41.0 / 100

1Yr Price target upside is 304%

1 analysts

CASI Pharma Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

CASI Pharma Inc Live Stock Price Today, Share Analysis and Chart

CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is us...

67.96% Fall from 52W High

SWOT Analysis

CASI Pharma Inc Live Price Chart